NHS Executive North West R&D Directorate (£120,000, 2000-3), Lupus UK (£44,500, 2004-7) and Arthritis UK (£98,727, 2011-14).
MacElhone K, Teh LS, Abbott J. (2006). Quality of life in systemic lupus erythematosus: a review. Lupus;15:633-643.
MacElhone K, Abbott J, Teh LS et al. (2007). The development and validation of a disease-specific quality of life instrument for adults with systemic lupus erythematosus. Arthritis Care and Research 57:972-979..
McElhone K, Abbott J, Gray J & Williams A, Teh LS. Patient perspective of Systemic Lupus Erythematosus in relation to Health-related Quality of Life Concepts. A Qualitative Study. Lupus 2010;19:1640-1647.
McElhone K, Castelino M, Abbott J, Bruce IN, Ahmad Y, Shelmerdine J, Peers K, Isenberg D,Ferenkeh-Koroma A, Griffiths B, Akil M, Maddison P, Gordon C, & Teh LS. The LupusQoL and associations with demographic and clinical parameters in patients with Systemic Lupus Erythematosus (SLE). Journal of Rheumatology 2010;37:2273-2279.
Castelino M, Abbott J, McElhone K, Teh LS. Comparison of the psychometric properties of Health-Related Quality of Life Measures used in adults with systemic lupus erythematosus: A systematic review of the literature. Rheumatology 2013; 52: 684-696.